NEJM· Matthew J. Frigault Binod Dhakal Andrzej J. Jakubowiak Noopur Raje Kamalika Banerjee C. Jenny Mu Kevin C. Hart Sigal Shachar Lawrence P. Andrews Laurene S. Cheung Faith M. Griffin Alexandra R. Witter Michael Hyde Chester Pham Nikitha Gandra Tenzin Shakya Bhargavi Rajan Christa Cortesio Samuel T. Haile Heba Nowyhed Priyanka Nair-Gupta Priyam Mitra Rebecca J. Chan Ana Kostic Christopher R. Heery Jacalyn Rosenblatt and Michael R. Bishop·· 7 天前精选AI 评分57
Anito-cel（d-Domain BCMA CAR-T）治疗复发或难治性骨髓瘤的1期研究
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
AI 导读
NEJM 2026年9月24日第395卷第12期发表Anito-cel的1期研究，该产品为靶向BCMA的d-Domain CAR-T细胞疗法，用于复发或难治性骨髓瘤。文章页码为1180-1192，作者包括Matthew J. Frigault、Binod Dhakal、Andrzej J. Jakubowiak、Noopur Raje等。
来源：NEJM · nejm.org